FDA Drug Recalls

Recalls / Class II

Class IID-0510-2017

Product

Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only, Manufactured by: LEO Pharma Inc., Dublin, Ireland, Manufactured for: Prasco Laboratories, Mason, OH, 45040

Brand name
Calcipotriene
Generic name
Calcipotriene
Active ingredient
Calcipotriene
Route
Topical
NDC
66993-877
FDA application
NDA020554
Affected lot / code info
Lot #: a) EK8760, Exp 2/17; EL1115, Exp 3/17; EL2358, Exp 4/17; EL6143, Exp 7/17; EM0837, Exp 10/17; EM2088, 12/17; A20899, Exp 5/18; A24492, Exp 6/18; b) EK8764, Exp 2/17; EL6145, Exp 7/17; EM2091, Exp 2/17; A25206, Exp 6/18.

Why it was recalled

Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling.

Recalling firm

Firm
LEO PHARMA INC
Manufacturer
Prasco Laboratories
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7 Giralda Farms, N/A, Madison, New Jersey 07940-1051

Distribution

Quantity
272,062 tubes
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2017-01-19
FDA classified
2017-03-03
Posted by FDA
2017-03-15
Terminated
2018-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0510-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.